-       Report 
- January 2025
-  130 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- October 2025
-  180 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  209 Pages 
- Global 
   From       €4159EUR$4,650USD£3,659GBP 
            -       Report 
- August 2025
-  197 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
           -       Report 
- October 2025
-  307 Pages 
- Global 
   From       €6257EUR$6,995USD£5,504GBP 
          -       Report 
- November 2024
-  471 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
            -       Report 
- April 2025
-  143 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- August 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  214 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- July 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- October 2025
-  186 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  186 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- November 2025
-  177 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
       
      The Research Grade Proteins market is a key component of the drug discovery process. Proteins are essential for understanding the structure and function of biological systems, and are used to develop new drugs and therapies. Research grade proteins are produced in a highly controlled environment, ensuring that they are of the highest quality and purity. They are used in a variety of applications, including drug screening, target identification, and biomarker discovery.
Research grade proteins are    used in a variety of drug discovery processes, including high-throughput screening, structure-based drug design, and protein-protein interaction studies. They are also used in the development of novel therapeutic agents, such as monoclonal antibodies and small molecule drugs.
Companies in the Research Grade Proteins market include Abcam, Bio-Techne, Merck KGaA, Thermo Fisher Scientific, and GenScript. Show Less   Read more